From Office of TX Attorney General <[email protected]>
Subject Paxton Announces that Texas Has Joined $2.37 Billion Settlement With Opioid Manufacturer Allergan
Date January 20, 2023 10:10 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Seal________________________________________________________________________




*FOR IMMEDIATE RELEASE*

January 20, 2023

www.texasattorneygeneral.gov




*PRESS OFFICE: (512) 463-2050*

[email protected]





?

*Paxton Announces that Texas Has Joined $2.37 Billion Settlement?*?

*With Opioid Manufacturer Allergan*?

?

AUSTIN ??Attorney General Paxton announced that Texas is joining a $2.37 billion settlement with opioid manufacturer Allergan for its role in the nationwide opioid epidemic. The agreement in principle was previously announced in July 2022 [ [link removed] ]. Under the settlement, over $135 million is designated for Texas and its local governments. Allergan will pay participating states and local governments over a period of seven years.??

?

The company formerly made generic opioids as well as Norco- and Kadian-branded opioids. Allergan sold its generics portfolio, including opioid products, to Teva in 2016. The states negotiated the agreements jointly with Allergan and Teva Pharmaceuticals. Texas settled separately with Teva in February 2022 for $150 million in cash and $75 million worth of Narcan, which is a lifesaving intervention for opioid overdoses used by first responders.?

?

The coalition of states alleged that Allergan deceptively marketed opioids by downplaying the risk of addiction, overstating their benefits, and encouraging doctors to treat patients showing signs of addiction by prescribing them more opioids. They also alleged that Allergan failed to maintain effective controls to prevent diversion of opioids.?

?

?I am pleased to announce yet another settlement to help get accountability for those who have created and worsened this crisis,? said Attorney General Paxton. ?This settlement will not only help get justice for those who have suffered because of Allergan?s reckless actions, but it will also provide funds to stop the irresponsible distribution of opioids and help individuals battling addiction.???

?

Under the agreement, Allergan must share clinical data through a third-party archive, disclose documents through a public repository, and stop selling opioids. Allergan also cannot fund or provide grants to third parties for promoting opioids or lobby on matters related to opioids.????

?

This agreement is one of many opioid settlements that Attorney General Paxton has negotiated for Texas. Attorney General Paxton has secured over approximately $2.5 billion for Texas from those who have worsened the opioid crisis, including Allergan, Wal-Mart [ [link removed] ], CVS [ [link removed] ], Mallinckrodt [ [link removed] ], Teva [ [link removed] ], Endo [ [link removed] ], Johnson & Johnson [ [link removed] ], McKinsey [ [link removed] ], and others.??

? ?

###







Stay Connected with Office of Texas Attorney General on
Facebook [ [link removed] ]?-?Twitter [ [link removed] ]?-?Instagram [ [link removed] ]?-?Email [ [link removed] ]

?Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page [ [link removed] ]. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com [ [link removed] ].


________________________________________________________________________

This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: Office of Texas Attorney General ?300 W. 15th Street?? Austin, TX?78701 GovDelivery logo [ [link removed] ]
Screenshot of the email generated on import

Message Analysis